CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: antimony atom
Accession: CHEBI:30513
browse the term
Definition: A pnictogen that has formula Sb.
Synonyms: related_synonym: 51Sb; Antimon; Formula=Sb; InChI=1S/Sb; InChIKey=WATWJIUSRGPENY-UHFFFAOYSA-N; SMILES=[Sb]; Sb; antimoine; antimonio; antimony; stibium
xref: WebElements:Sb
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD
PMID:32076005
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA
CTD
PMID:32076005
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Akr1b10
aldo-keto reductase family 1 member B10
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD
PMID:32076005
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c3
aldo-keto reductase family 1, member C3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD
PMID:32076005
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA
CTD
PMID:32076005
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh3b2
aldehyde dehydrogenase 3 family, member B2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705 Ensembl chr 1:201,253,157...201,264,705
G
Aldh3b3
aldehyde dehydrogenase 3 family, member B3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
G
Barx2
BARX homeobox 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA
CTD
PMID:32076005
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
G
Bmp4
bone morphogenetic protein 4
multiple interactions decreases expression
ISO
RTKI cpd inhibits the reaction [antimonite results in decreased expression of BMP4 mRNA]
CTD
PMID:17400267
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Btf3
basic transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA
CTD
PMID:32076005
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
G
Btg2
BTG anti-proliferation factor 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA
CTD
PMID:32076005
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Calr
calreticulin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA
CTD
PMID:32076005
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Cbr1
carbonyl reductase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA
CTD
PMID:32076005
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA
CTD
PMID:32076005
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA
CTD
PMID:32076005
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cnbp
CCHC-type zinc finger, nucleic acid binding protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA
CTD
PMID:32076005
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA
CTD
PMID:32076005
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Dhrs9
dehydrogenase/reductase 9
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA
CTD
PMID:32076005
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA
CTD
PMID:32076005
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA
CTD
PMID:32076005
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dsc1
desmocollin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD
PMID:32076005
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsg1
desmoglein 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]
CTD
PMID:32076005
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Egfr
epidermal growth factor receptor
increases expression
ISO
antimonite results in increased expression of EGFR protein
CTD
PMID:17400267
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr3
early growth response 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA
CTD
PMID:32076005
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehf
ets homologous factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA
CTD
PMID:32076005
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
G
Elf3
E74 like ETS transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA
CTD
PMID:32076005
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Epha1
Eph receptor A1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein
CTD
PMID:32076005
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
G
Epha2
Eph receptor A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein
CTD
PMID:32076005
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA
CTD
PMID:32076005
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA
CTD
PMID:32076005
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Flg
filaggrin
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD
PMID:32076005
NCBI chr 2:178,884,793...178,912,986
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA
CTD
PMID:32076005
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxq1
forkhead box Q1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA
CTD
PMID:32076005
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA
CTD
PMID:32076005
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA
CTD
PMID:32076005
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD
PMID:32076005
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD
PMID:32076005
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA
CTD
PMID:32076005
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Glrx
glutaredoxin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA
CTD
PMID:32076005
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA
CTD
PMID:32076005
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Grhl1
grainyhead-like transcription factor 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA
CTD
PMID:32076005
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Gsto1
glutathione S-transferase omega 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA
CTD
PMID:32076005
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Hltf
helicase-like transcription factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA
CTD
PMID:32076005
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD
PMID:32076005
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hopx
HOP homeobox
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA
CTD
PMID:32076005
NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA
CTD
PMID:32076005
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA
CTD
PMID:32076005
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb8
heat shock protein family B (small) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA
CTD
PMID:32076005
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Htatip2
HIV-1 Tat interactive protein 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA
CTD
PMID:32076005
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Id1
inhibitor of DNA binding 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA
CTD
PMID:32076005
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ikzf2
IKAROS family zinc finger 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA
CTD
PMID:32076005
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA
CTD
PMID:32076005
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Ivl
involucrin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD
PMID:32076005
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Klf5
KLF transcription factor 5
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA
CTD
PMID:32076005
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Krt1
keratin 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]
CTD
PMID:32076005
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
G
Krt10
keratin 10
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD
PMID:32076005
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Loricrin
loricrin cornified envelope precursor protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA
CTD
PMID:32076005
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
G
Maoa
monoamine oxidase A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA
CTD
PMID:32076005
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA
CTD
PMID:32076005
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32076005
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32076005
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mgst1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA
CTD
PMID:32076005
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mmp7
matrix metallopeptidase 7
increases expression multiple interactions
ISO
antimonite results in increased expression of MMP7 mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of MMP7 mRNA]
CTD
PMID:17400267
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA
CTD
PMID:32076005
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD
PMID:32076005
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Osm
oncostatin M
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]
CTD
PMID:32076005
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pbx1
PBX homeobox 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA
CTD
PMID:32076005
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:32076005
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA
CTD
PMID:32076005
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pir
pirin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA
CTD
PMID:32076005
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pitx1
paired-like homeodomain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA
CTD
PMID:32076005
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression multiple interactions
ISO
antimonite results in increased expression of PPARD mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of PPARD mRNA]
CTD
PMID:17400267
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA
CTD
PMID:32076005
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA
CTD
PMID:32076005
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA
CTD
PMID:32076005
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA
CTD
PMID:32076005
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA
CTD
PMID:32076005
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA
CTD
PMID:32076005
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Sult1c3
sulfotransferase family 1C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA
CTD
PMID:32076005
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
G
Sult1e1
sulfotransferase family 1E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA
CTD
PMID:32076005
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2b1
sulfotransferase family 2B member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA
CTD
PMID:32076005
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Tgm1
transglutaminase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA
CTD
PMID:32076005
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tp63
tumor protein p63
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA
CTD
PMID:32076005
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tsc22d3
TSC22 domain family, member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:32076005
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Txn1
thioredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA
CTD
PMID:32076005
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD
PMID:32076005
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA
CTD
PMID:32076005
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Atf6
activating transcription factor 6
multiple interactions increases expression
ISO
[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA antimony trichloride results in increased expression of ATF6 mRNA
CTD
PMID:34091186
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
multiple interactions decreases expression
ISO
[Arsenic Trioxide co-treated with antimony trichloride] results in decreased expression of ATP2A2 mRNA; Arsenic Trioxide promotes the reaction [antimony trichloride results in decreased expression of ATP2A2 protein] antimony trichloride results in decreased expression of ATP2A2 mRNA; antimony trichloride results in decreased expression of ATP2A2 protein
CTD
PMID:34091186
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
multiple interactions
ISO
[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of CAMK2G mRNA
CTD
PMID:34091186
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
G
Casp12
caspase 12
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of CASP12 mRNA [arsenic trichloride co-treated with antimony trichloride] results in increased expression of CASP12 mRNA
CTD
PMID:34091186
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
increases cleavage increases expression multiple interactions
ISO
antimony trichloride results in increased cleavage of CASP3 protein antimony trichloride results in increased expression of CASP3 mRNA arsenic trichloride promotes the reaction [antimony trichloride results in increased cleavage of CASP3 protein]; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of CASP3 mRNA]
CTD
PMID:30055241 PMID:34091186
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ddb1
damage-specific DNA binding protein 1
decreases expression
ISO
antimony trichloride results in decreased expression of DDB1 mRNA; antimony trichloride results in decreased expression of DDB1 protein
CTD
PMID:20509621
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of DDIT3 mRNA; antimony trichloride results in increased expression of DDIT3 protein antimony trichloride promotes the reaction [arsenic trichloride results in increased expression of DDIT3 protein]; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of DDIT3 mRNA]; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of DDIT3 protein]
CTD
PMID:34091186
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ern2
endoplasmic reticulum to nucleus signaling 2
multiple interactions increases expression
ISO
[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ERN2 mRNA antimony trichloride results in increased expression of ERN2 mRNA
CTD
PMID:34091186
NCBI chr 1:176,726,454...176,743,289
Ensembl chr 1:176,726,454...176,743,289
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of HSPA5 mRNA; antimony trichloride results in increased expression of HSPA5 protein [arsenic trichloride co-treated with antimony trichloride] results in increased expression of HSPA5 protein; antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Arsenic Trioxide promotes the reaction [antimony trichloride results in increased expression of HSPA5 mRNA]
CTD
PMID:34091186
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of ITPR2 mRNA antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of ITPR2 mRNA]; Arsenic Trioxide promotes the reaction [antimony trichloride results in increased expression of ITPR2 mRNA]
CTD
PMID:34091186
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
antimony trichloride results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK1 protein]
CTD
PMID:30055241
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
antimony trichloride results in increased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK3 protein]
CTD
PMID:30055241
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of MAPK8 protein [arsenic trichloride co-treated with antimony trichloride] results in increased expression of MAPK8 mRNA; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of MAPK8 protein]
CTD
PMID:34091186
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Ryr2
ryanodine receptor 2
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of RYR2 mRNA; antimony trichloride results in increased expression of RYR2 protein [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of RYR2 mRNA; antimony trichloride promotes the reaction [Arsenic Trioxide results in decreased expression of RYR2 protein]; Arsenic Trioxide promotes the reaction [antimony trichloride results in decreased expression of RYR2 protein]
CTD
PMID:34091186
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
G
Sirt1
sirtuin 1
decreases expression multiple interactions
ISO
antimony trichloride results in decreased expression of SIRT1 mRNA; antimony trichloride results in decreased expression of SIRT1 protein Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Cycloheximide promotes the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Dactinomycin affects the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; U 0126 inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]
CTD
PMID:30055241
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
antimony trichloride results in increased expression of TRP53 mRNA; antimony trichloride results in increased expression of TRP53 protein antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of TRP53 protein]; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of TRP53 mRNA]; arsenic trichloride promotes the reaction [antimony trichloride results in increased expression of TRP53 protein]; Arsenic Trioxide promotes the reaction [antimony trichloride results in increased expression of TRP53 protein]
CTD
PMID:34091186
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Xbp1
X-box binding protein 1
multiple interactions increases expression
ISO
[arsenic trichloride co-treated with antimony trichloride] results in increased expression of XBP1 mRNA; antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]; arsenic trichloride inhibits the reaction [antimony trichloride results in increased expression of XBP1 protein] antimony trichloride results in increased expression of XBP1 mRNA; antimony trichloride results in increased expression of XBP1 protein
CTD
PMID:34091186
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xpa
XPA, DNA damage recognition and repair factor
multiple interactions affects binding
ISO
antimony trichloride inhibits the reaction [XPA protein binds to Zinc] antimony trichloride binds to XPA protein
CTD
PMID:20509621
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
G
A2m
alpha-2-macroglobulin
decreases expression
ISO
Antimony results in decreased expression of A2M mRNA
CTD
PMID:17547211
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcc1
ATP binding cassette subfamily C member 1
decreases response to substance multiple interactions
ISO
ABCC1 protein results in decreased susceptibility to Antimony; ABCC1 protein results in decreased susceptibility to Antimony analog GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony]
CTD
PMID:7954421 PMID:11560771
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Acp2
acid phosphatase 2, lysosomal
decreases expression
ISO
Antimony results in decreased expression of ACP2 mRNA
CTD
PMID:17547211
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
Antimony results in decreased expression of ACSL1 mRNA
CTD
PMID:17547211
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Adm
adrenomedullin
increases expression
ISO
Antimony results in increased expression of ADM mRNA
CTD
PMID:17547211
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Akr1b1
aldo-keto reductase family 1 member B1
decreases expression
ISO
Antimony results in decreased expression of AKR1B1 mRNA
CTD
PMID:17547211
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
Antimony results in decreased expression of ALDH6A1 mRNA
CTD
PMID:17547211
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aqp9
aquaporin 9
multiple interactions
ISO
AQP9 protein results in increased uptake of and results in increased susceptibility to Antimony
CTD
PMID:15336539
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
ISO
Antimony results in decreased expression of ATP2B1 mRNA
CTD
PMID:17547211
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
ISO
Antimony results in decreased expression of AZGP1 mRNA
CTD
PMID:17547211
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of BAX protein
CTD
PMID:32920012
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP ISO
666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein
CTD
PMID:32920012
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased cleavage of CASP3 protein
CTD
PMID:32920012
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
Antimony results in increased expression of CCL2 mRNA
CTD
PMID:37858840
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccnb2
cyclin B2
increases expression
ISO
Antimony results in increased expression of CCNB2 mRNA
CTD
PMID:17547211
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
multiple interactions
EXP
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]
CTD
PMID:34571074
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression decreases expression
ISO
Antimony results in increased expression of CDKN1A mRNA Antimony results in decreased expression of CDKN1A mRNA
CTD
PMID:17547211 PMID:37858840
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
Antimony results in increased expression of CDKN3 mRNA
CTD
PMID:17547211
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Antimony results in increased expression of CEBPB protein
CTD
PMID:37858840
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cfb
complement factor B
decreases expression
ISO
Antimony results in decreased expression of CFB mRNA
CTD
PMID:17547211
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
Antimony results in increased phosphorylation of [CHUK protein co-treated with IKBKB protein]
CTD
PMID:37858840
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Cks2
CDC28 protein kinase regulatory subunit 2
increases expression
ISO
Antimony results in increased expression of CKS2 mRNA
CTD
PMID:17547211
NCBI chr17:13,570,611...13,575,770
G
Clgn
calmegin
decreases expression
ISO
Antimony results in decreased expression of CLGN mRNA
CTD
PMID:17547211
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
G
Clptm1
CLPTM1 regulator of GABA type A receptor forward trafficking
decreases expression
ISO
Antimony results in decreased expression of CLPTM1 mRNA
CTD
PMID:17547211
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein; pyrazolanthrone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]
CTD
PMID:32920012 PMID:34571074
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Dazap1
DAZ associated protein 1
increases expression
ISO
Antimony results in increased expression of DAZAP1 mRNA
CTD
PMID:17547211
NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818
G
Dcp1a
decapping mRNA 1A
increases expression
ISO
Antimony results in increased expression of DCP1A mRNA
CTD
PMID:17547211
NCBI chr16:5,656,960...5,702,151
Ensembl chr16:5,656,773...5,702,140
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Antimony results in increased expression of DDIT3 mRNA
CTD
PMID:37858840
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Antimony results in increased expression of DUSP1 mRNA
CTD
PMID:17547211
NCBI chr10:16,680,478...16,683,275
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation
ISO
Antimony results in increased phosphorylation of EIF2A protein
CTD
PMID:37858840
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
F5
coagulation factor V
decreases expression
ISO
Antimony results in decreased expression of F5 mRNA
CTD
PMID:17547211
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fabp4
fatty acid binding protein 4
increases expression
ISO
Antimony results in increased expression of FABP4 mRNA
CTD
PMID:37858840
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fasn
fatty acid synthase
increases expression
ISO
Antimony results in increased expression of FASN mRNA
CTD
PMID:37858840
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
Antimony results in decreased expression of FDFT1 mRNA
CTD
PMID:17547211
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
Antimony results in decreased expression of FDPS mRNA
CTD
PMID:17547211
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Antimony results in increased expression of FOSL1 mRNA
CTD
PMID:17547211
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony]
CTD
PMID:11560771
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
Antimony results in increased expression of GCNT3 mRNA
CTD
PMID:17547211
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]
CTD
PMID:34571074
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Ghitm
growth hormone inducible transmembrane protein
decreases expression
ISO
Antimony results in decreased expression of GHITM mRNA
CTD
PMID:17547211
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
G
Gla
galactosidase, alpha
increases expression
ISO
Antimony results in increased expression of GLA mRNA
CTD
PMID:17547211
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
G
Gpx4
glutathione peroxidase 4
multiple interactions decreases expression
ISO
ferrostatin-1 inhibits the reaction [Antimony results in decreased expression of GPX4 protein] Acetylcysteine inhibits the reaction [Antimony results in decreased expression of GPX4 protein]; Antimony results in decreased expression of and results in increased localization of and results in increased degradation of GPX4 protein; Chloroquine inhibits the reaction [Antimony results in decreased expression of GPX4 protein]; Cyclophosphamide promotes the reaction [Antimony results in decreased expression of and results in increased degradation of GPX4 protein]; MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of GPX4 protein]; MCOLN1 protein promotes the reaction [Antimony results in increased degradation of GPX4 protein]
CTD
PMID:38097005
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gtpbp6
GTP binding protein 6 (putative)
increases expression
ISO
Antimony results in increased expression of GTPBP6 mRNA
CTD
PMID:17547211
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression multiple interactions
ISO
Antimony results in increased expression of HAVCR1 protein ferrostatin-1 inhibits the reaction [Antimony results in increased expression of HAVCR1 protein] Acetylcysteine inhibits the reaction [Antimony results in increased expression of HAVCR1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HAVCR1 protein]
CTD
PMID:38097005
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hmga1
high mobility group AT-hook 1
increases expression
ISO
Antimony results in increased expression of HMGA1 mRNA
CTD
PMID:17547211
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmox1
heme oxygenase 1
increases expression
ISO
Antimony results in increased expression of HMOX1 mRNA
CTD
PMID:17547211
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
ISO
Antimony results in decreased expression of HSD17B2 mRNA
CTD
PMID:17547211
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
decreases expression
ISO
Antimony results in decreased expression of HSD17B7 mRNA
CTD
PMID:17547211
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
multiple interactions increases expression
ISO
MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSP90AA1 protein]
CTD
PMID:38097005
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression multiple interactions
ISO
Antimony results in increased expression of HSP90AB1 protein MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSP90AB1 protein]
CTD
PMID:38097005
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Antimony results in increased expression of HSPA5 mRNA
CTD
PMID:37858840
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions increases expression
ISO
MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSPA8 protein]
CTD
PMID:38097005
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Ier2
immediate early response 2
increases expression
ISO
Antimony results in increased expression of IER2 mRNA
CTD
PMID:17547211
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
G
Ifng
interferon gamma
affects response to substance
ISO
IFNG protein affects the susceptibility to Antimony
CTD
PMID:11035738
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd1
interferon-related developmental regulator 1
decreases expression
ISO
Antimony results in decreased expression of IFRD1 mRNA
CTD
PMID:17547211
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
Antimony results in increased phosphorylation of [CHUK protein co-treated with IKBKB protein]
CTD
PMID:37858840
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il12a
interleukin 12A
affects response to substance
ISO
IL12A protein affects the susceptibility to Antimony
CTD
PMID:11023473
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
affects response to substance
ISO
IL12B protein affects the susceptibility to Antimony
CTD
PMID:11023473
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il6
interleukin 6
increases expression
ISO
Antimony results in increased expression of IL6 mRNA
CTD
PMID:37858840
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ing3
inhibitor of growth family, member 3
increases expression
ISO
Antimony results in increased expression of ING3 mRNA
CTD
PMID:17547211
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Itgb3bp
integrin subunit beta 3 binding protein
increases expression
ISO
Antimony results in increased expression of ITGB3BP mRNA
CTD
PMID:17547211
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
decreases expression
ISO
Antimony results in decreased expression of ITIH3 mRNA
CTD
PMID:17547211
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
G
Klf6
KLF transcription factor 6
increases expression
ISO
Antimony results in increased expression of KLF6 mRNA
CTD
PMID:17547211
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Lamp2
lysosomal-associated membrane protein 2
increases expression multiple interactions
ISO
Antimony results in increased expression of LAMP2 protein MCOLN1 protein inhibits the reaction [Antimony results in increased expression of LAMP2 protein]
CTD
PMID:38097005
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Lipa
lipase A, lysosomal acid type
decreases expression
ISO
Antimony results in decreased expression of LIPA mRNA
CTD
PMID:17547211
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Lrrk2
leucine-rich repeat kinase 2
decreases expression multiple interactions
ISO
Antimony results in decreased expression of LRRK2 protein MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of LRRK2 protein]
CTD
PMID:38097005
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
G
Lss
lanosterol synthase
decreases expression
ISO
Antimony results in decreased expression of LSS mRNA
CTD
PMID:17547211
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Antimony results in increased expression of MAFF mRNA
CTD
PMID:17547211
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Man1a2
mannosidase, alpha, class 1A, member 2
decreases expression
ISO
Antimony results in decreased expression of MAN1A2 mRNA
CTD
PMID:17547211
NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32920012 PMID:34571074
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32920012 PMID:34571074
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcm2
minichromosome maintenance complex component 2
increases expression
ISO
Antimony results in increased expression of MCM2 mRNA
CTD
PMID:17547211
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcoln1
mucolipin TRP cation channel 1
decreases expression multiple interactions
ISO
Antimony results in decreased expression of MCOLN1 protein MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of GPX4 protein]; MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of LRRK2 protein]; MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of MEF2D protein]; MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of SOD1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HAVCR1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSP90AA1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSP90AB1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of HSPA8 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of LAMP2 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of PTGS2 protein]; MCOLN1 protein promotes the reaction [Antimony results in increased degradation of GPX4 protein]
CTD
PMID:38097005
NCBI chr12:1,560,341...1,574,252
Ensembl chr12:1,560,359...1,574,252
G
Mef2d
myocyte enhancer factor 2D
decreases expression multiple interactions
ISO
Antimony results in decreased expression of MEF2D protein MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of MEF2D protein]
CTD
PMID:38097005
NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457
G
Mgat2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
ISO
Antimony results in decreased expression of MGAT2 mRNA
CTD
PMID:17547211
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
G
Mir196b
microRNA 196b
multiple interactions
ISO
[Air Pollutants, Occupational results in increased abundance of Antimony] which results in increased expression of MIR196B mRNA
CTD
PMID:27506416
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
G
Ndrg2
NDRG family member 2
decreases expression
ISO
Antimony results in decreased expression of NDRG2 mRNA
CTD
PMID:17547211
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Nfkbia
NFKB inhibitor alpha
decreases expression
ISO
Antimony results in decreased expression of NFKBIA mRNA
CTD
PMID:17547211
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]
CTD
PMID:34571074
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
decreases expression
ISO
Antimony results in decreased expression of NR0B2 mRNA
CTD
PMID:17547211
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Os9
OS9, endoplasmic reticulum lectin
decreases expression
ISO
Antimony results in decreased expression of OS9 mRNA
CTD
PMID:17547211
NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PCNA protein
CTD
PMID:34571074
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
Antimony results in decreased expression of PDIA4 mRNA
CTD
PMID:17547211
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pgc
progastricsin
decreases expression
ISO
Antimony results in decreased expression of PGC mRNA
CTD
PMID:17547211
NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682
G
Pml
PML nuclear body scaffold
multiple interactions
ISO
Antimony affects the localization of and results in increased sumoylation of PML protein
CTD
PMID:26049103
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression multiple interactions
ISO
Antimony results in increased expression of PPARG protein Fulvestrant inhibits the reaction [Antimony results in increased expression of PPARG protein]
CTD
PMID:37858840
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppih
peptidylprolyl isomerase H
increases expression
ISO
Antimony results in increased expression of PPIH mRNA
CTD
PMID:17547211
NCBI chr 5:132,906,324...132,924,341
Ensembl chr 5:132,906,328...132,924,267
G
Psph
phosphoserine phosphatase
decreases expression
ISO
Antimony results in decreased expression of PSPH mRNA
CTD
PMID:17547211
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
Antimony results in increased expression of PTGS2 protein Acetylcysteine inhibits the reaction [Antimony results in increased expression of PTGS2 protein]; MCOLN1 protein inhibits the reaction [Antimony results in increased expression of PTGS2 protein]
CTD
PMID:37858840 PMID:38097005
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
Antimony results in increased expression of PTTG1 mRNA
CTD
PMID:17547211
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rbpms
RNA binding protein, mRNA processing factor
increases expression
ISO
Antimony results in increased expression of RBPMS mRNA
CTD
PMID:17547211
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
G
Rela
RELA proto-oncogene, NF-kB subunit
increases localization
ISO
Antimony results in increased localization of RELA protein
CTD
PMID:37858840
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rfc2
replication factor C subunit 2
increases expression
ISO
Antimony results in increased expression of RFC2 mRNA
CTD
PMID:17547211
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rnaseh2a
ribonuclease H2, subunit A
increases expression
ISO
Antimony results in increased expression of RNASEH2A mRNA
CTD
PMID:17547211
NCBI chr19:23,186,325...23,196,045
Ensembl chr19:23,186,383...23,196,041
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
Antimony results in decreased expression of SCD mRNA
CTD
PMID:17547211
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sephs2
selenophosphate synthetase 2
decreases expression
ISO
Antimony results in decreased expression of SEPHS2 mRNA
CTD
PMID:17547211
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
Antimony results in decreased expression of SERPINB1 mRNA
CTD
PMID:17547211
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Serpinc1
serpin family C member 1
decreases expression
ISO
Antimony results in decreased expression of SERPINC1 mRNA
CTD
PMID:17547211
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Sik1
salt-inducible kinase 1
increases expression
ISO
Antimony results in increased expression of SIK1 mRNA
CTD
PMID:17547211
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Snrpa
small nuclear ribonucleoprotein polypeptide A
increases expression
ISO
Antimony results in increased expression of SNRPA mRNA
CTD
PMID:17547211
NCBI chr 1:82,481,770...82,490,540
Ensembl chr 1:82,481,770...82,490,538
G
Sod1
superoxide dismutase 1
decreases expression multiple interactions
ISO
Antimony results in decreased expression of SOD1 protein Acetylcysteine inhibits the reaction [Antimony results in decreased expression of SOD1 protein]; ferrostatin-1 inhibits the reaction [Antimony results in decreased expression of SOD1 protein]; MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of SOD1 protein]
CTD
PMID:38097005
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sqle
squalene epoxidase
decreases expression
ISO
Antimony results in decreased expression of SQLE mRNA
CTD
PMID:17547211
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
ISO
Antimony results in increased expression of SREBF1 mRNA
CTD
PMID:37858840
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srsf1
serine and arginine rich splicing factor 1
decreases expression
ISO
Antimony results in decreased expression of SRSF1 mRNA
CTD
PMID:17547211
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
G
Srsf5
serine and arginine rich splicing factor 5
decreases expression
ISO
Antimony results in decreased expression of SRSF5 mRNA
CTD
PMID:17547211
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
decreases expression
ISO
Antimony results in decreased expression of ST6GALNAC4 mRNA
CTD
PMID:17547211
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
Tardbp
TAR DNA binding protein
decreases expression
ISO
Antimony results in decreased expression of TARDBP mRNA
CTD
PMID:17547211
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
G
Tnf
tumor necrosis factor
increases expression
ISO
Antimony results in increased expression of TNF mRNA
CTD
PMID:37858840
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Antimony results in increased expression of TNFAIP3 mRNA
CTD
PMID:17547211
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Antimony results in decreased expression of TNFSF10 mRNA
CTD
PMID:17547211
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tob1
transducer of ErbB-2.1
decreases expression
ISO
Antimony results in decreased expression of TOB1 mRNA
CTD
PMID:17547211
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Tspan7
tetraspanin 7
decreases expression
ISO
Antimony results in decreased expression of TSPAN7 mRNA
CTD
PMID:17547211
NCBI chr X:12,208,783...12,306,092
Ensembl chr X:12,208,783...12,306,131
G
Tuft1
tuftelin 1
increases expression
ISO
Antimony results in increased expression of TUFT1 mRNA
CTD
PMID:17547211
NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:182,260,398...182,306,192
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Antimony results in increased expression of TXNRD1 mRNA
CTD
PMID:17547211
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyms
thymidylate synthetase
increases expression
ISO
Antimony results in increased expression of TYMS mRNA
CTD
PMID:17547211
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ube2c
ubiquitin-conjugating enzyme E2C
increases expression
ISO
Antimony results in increased expression of UBE2C mRNA
CTD
PMID:17547211
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Xbp1
X-box binding protein 1
increases expression
ISO
Antimony results in increased expression of XBP1 protein
CTD
PMID:37858840
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Zwint
ZW10 interacting kinetochore protein
increases expression
ISO
Antimony results in increased expression of ZWINT mRNA
CTD
PMID:17547211
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
G
A2m
alpha-2-macroglobulin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of A2M mRNA
CTD
PMID:17547211
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcc1
ATP binding cassette subfamily C member 1
affects response to substance decreases response to substance increases secretion multiple interactions
ISO
ABCC1 protein affects the susceptibility to Antimony Potassium Tartrate ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate ABCC1 protein results in increased secretion of Antimony Potassium Tartrate [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate; Glutathione affects the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]
CTD
PMID:10025956 PMID:10348353 PMID:11278867 PMID:12018890 PMID:12731862
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression multiple interactions
EXP ISO
Antimony Potassium Tartrate results in increased expression of ABCC2 mRNA; Antimony Potassium Tartrate results in increased expression of ABCC2 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD
PMID:11408547 PMID:32076005
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA
CTD
PMID:32076005
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Acp2
acid phosphatase 2, lysosomal
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ACP2 mRNA
CTD
PMID:17547211
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ACSL1 mRNA
CTD
PMID:17547211
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Adm
adrenomedullin
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ADM mRNA
CTD
PMID:17547211
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Akr1b1
aldo-keto reductase family 1 member B1
decreases expression increases expression
ISO
Antimony Potassium Tartrate results in decreased expression of AKR1B1 mRNA Antimony Potassium Tartrate results in increased expression of AKR1B1 mRNA
CTD
PMID:17547211 PMID:28713220
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of AKR1B10 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of AKR1C2 protein
CTD
PMID:28713220
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of AKR1C3 mRNA; Antimony Potassium Tartrate results in increased expression of AKR1C3 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA
CTD
PMID:32076005
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh3b2
aldehyde dehydrogenase 3 family, member B2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705 Ensembl chr 1:201,253,157...201,264,705
G
Aldh3b3
aldehyde dehydrogenase 3 family, member B3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ALDH6A1 mRNA
CTD
PMID:17547211
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ALDOA mRNA
CTD
PMID:28713220
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ALDOC mRNA
CTD
PMID:28713220
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Ar
androgen receptor
increases phosphorylation
ISO
Antimony Potassium Tartrate results in increased phosphorylation of AR protein
CTD
PMID:29462692
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ATP2B1 mRNA
CTD
PMID:17547211
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of AZGP1 mRNA
CTD
PMID:17547211
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
Barx2
BARX homeobox 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA
CTD
PMID:32076005
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of BAX protein
CTD
PMID:32920012
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP ISO
666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein
CTD
PMID:32920012
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmp6
bone morphogenetic protein 6
multiple interactions
ISO
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA]; Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]
CTD
PMID:28713220
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Btf3
basic transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA
CTD
PMID:32076005
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
G
Btg2
BTG anti-proliferation factor 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA
CTD
PMID:32076005
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Calml5
calmodulin-like 5
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of CALML5 mRNA
CTD
PMID:28713220
NCBI chr17:66,394,433...66,395,352
G
Calr
calreticulin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA
CTD
PMID:32076005
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Casp3
caspase 3
multiple interactions
EXP ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased cleavage of CASP3 protein
CTD
PMID:32920012
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cbr1
carbonyl reductase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA
CTD
PMID:32076005
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Ccnb2
cyclin B2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of CCNB2 mRNA
CTD
PMID:17547211
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
multiple interactions
EXP
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]
CTD
PMID:34571074
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of CDKN1A mRNA
CTD
PMID:17547211
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA
CTD
PMID:32076005
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of CDKN3 mRNA
CTD
PMID:17547211
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA
CTD
PMID:32076005
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cfb
complement factor B
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of CFB mRNA
CTD
PMID:17547211
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cks2
CDC28 protein kinase regulatory subunit 2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of CKS2 mRNA
CTD
PMID:17547211
NCBI chr17:13,570,611...13,575,770
G
Clgn
calmegin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of CLGN mRNA
CTD
PMID:17547211
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
G
Clptm1
CLPTM1 regulator of GABA type A receptor forward trafficking
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA
CTD
PMID:17547211
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
G
Cnbp
CCHC-type zinc finger, nucleic acid binding protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA
CTD
PMID:32076005
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein; pyrazolanthrone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]
CTD
PMID:32920012 PMID:34571074
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA
CTD
PMID:32076005
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Dazap1
DAZ associated protein 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of DAZAP1 mRNA
CTD
PMID:17547211
NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818
G
Dcp1a
decapping mRNA 1A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of DCP1A mRNA
CTD
PMID:17547211
NCBI chr16:5,656,960...5,702,151
Ensembl chr16:5,656,773...5,702,140
G
Dhrs9
dehydrogenase/reductase 9
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA
CTD
PMID:32076005
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA
CTD
PMID:32076005
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA
CTD
PMID:32076005
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dsc1
desmocollin 1
decreases expression multiple interactions
ISO
Antimony Potassium Tartrate results in decreased expression of DSC1 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsg1
desmoglein 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]
CTD
PMID:32076005
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Dst
dystonin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of DST protein
CTD
PMID:28713220
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Duox1
dual oxidase 1
multiple interactions decreases expression
ISO
Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA] Antimony Potassium Tartrate results in decreased expression of DUOX1 mRNA
CTD
PMID:29031483
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duoxa1
dual oxidase maturation factor 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of DUOXA1 mRNA
CTD
PMID:29031483
NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of DUSP1 mRNA
CTD
PMID:17547211
NCBI chr10:16,680,478...16,683,275
G
Dusp12
dual specificity phosphatase 12
multiple interactions
ISO
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA]
CTD
PMID:28713220
NCBI chr13:83,122,192...83,131,800
Ensembl chr13:83,122,193...83,131,285
G
Dusp2
dual specificity phosphatase 2
multiple interactions
ISO
Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]
CTD
PMID:28713220
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Egr3
early growth response 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA
CTD
PMID:32076005
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehf
ets homologous factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA
CTD
PMID:32076005
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
G
Elf3
E74 like ETS transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA
CTD
PMID:32076005
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Epha1
Eph receptor A1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein
CTD
PMID:32076005
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
G
Epha2
Eph receptor A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein
CTD
PMID:32076005
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA
CTD
PMID:32076005
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
F5
coagulation factor V
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of F5 mRNA
CTD
PMID:17547211
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fabp5
fatty acid binding protein 5
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of FABP5 mRNA
CTD
PMID:28713220
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of FDFT1 mRNA
CTD
PMID:17547211
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of FDPS mRNA
CTD
PMID:17547211
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA
CTD
PMID:32076005
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Flg
filaggrin
decreases expression multiple interactions
ISO
Antimony Potassium Tartrate results in decreased expression of FLG mRNA 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr 2:178,884,793...178,912,986
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA
CTD
PMID:32076005
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of FOSL1 mRNA
CTD
PMID:17547211
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxq1
forkhead box Q1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA
CTD
PMID:32076005
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fth1
ferritin heavy chain 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of FTH1 mRNA; Antimony Potassium Tartrate results in increased expression of FTH1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of FTL mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of G6PD mRNA; Antimony Potassium Tartrate results in increased expression of G6PD protein
CTD
PMID:28713220
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of GAPDH mRNA
CTD
PMID:28713220
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of GCLC mRNA; Antimony Potassium Tartrate results in increased expression of GCLC protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of GCLM mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of GCNT3 mRNA
CTD
PMID:17547211
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]
CTD
PMID:34571074
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA
CTD
PMID:32076005
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Ghitm
growth hormone inducible transmembrane protein
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of GHITM mRNA
CTD
PMID:17547211
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
G
Gla
galactosidase, alpha
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of GLA mRNA
CTD
PMID:17547211
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
G
Glrx
glutaredoxin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA
CTD
PMID:32076005
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA
CTD
PMID:32076005
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Grhl1
grainyhead-like transcription factor 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA
CTD
PMID:32076005
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Gsto1
glutathione S-transferase omega 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA
CTD
PMID:32076005
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Gtpbp6
GTP binding protein 6 (putative)
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of GTPBP6 mRNA
CTD
PMID:17547211
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
G
Hltf
helicase-like transcription factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA
CTD
PMID:32076005
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmga1
high mobility group AT-hook 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of HMGA1 mRNA
CTD
PMID:17547211
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of HMOX1 mRNA; Antimony Potassium Tartrate results in increased expression of HMOX1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD
PMID:17547211 PMID:28713220 PMID:32076005
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hopx
HOP homeobox
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA
CTD
PMID:32076005
NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of HSD17B2 mRNA
CTD
PMID:17547211
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of HSD17B7 mRNA
CTD
PMID:17547211
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA
CTD
PMID:32076005
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA
CTD
PMID:32076005
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb8
heat shock protein family B (small) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA
CTD
PMID:32076005
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Htatip2
HIV-1 Tat interactive protein 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA
CTD
PMID:32076005
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Id1
inhibitor of DNA binding 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA
CTD
PMID:32076005
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ier2
immediate early response 2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of IER2 mRNA
CTD
PMID:17547211
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
G
Ifrd1
interferon-related developmental regulator 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of IFRD1 mRNA
CTD
PMID:17547211
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ikzf2
IKAROS family zinc finger 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA
CTD
PMID:32076005
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA
CTD
PMID:32076005
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il4
interleukin 4
multiple interactions
ISO
Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA]
CTD
PMID:29031483
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Ing3
inhibitor of growth family, member 3
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ING3 mRNA
CTD
PMID:17547211
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Itgb3bp
integrin subunit beta 3 binding protein
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ITGB3BP mRNA
CTD
PMID:17547211
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ITIH3 mRNA
CTD
PMID:17547211
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
G
Ivl
involucrin
decreases expression multiple interactions
ISO
Antimony Potassium Tartrate results in decreased expression of IVL mRNA; Antimony Potassium Tartrate results in decreased expression of IVL protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Klf5
KLF transcription factor 5
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA
CTD
PMID:32076005
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Klf6
KLF transcription factor 6
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of KLF6 mRNA
CTD
PMID:17547211
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of KLK3 mRNA; Antimony Potassium Tartrate results in increased expression of KLK3 protein bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of KLK3 mRNA]
CTD
PMID:29462692
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Krt1
keratin 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]
CTD
PMID:32076005
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
G
Krt10
keratin 10
decreases expression multiple interactions
ISO
Antimony Potassium Tartrate results in decreased expression of KRT10 mRNA; Antimony Potassium Tartrate results in decreased expression of KRT10 protein 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD
PMID:28713220 PMID:32076005
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Krtdap
keratinocyte differentiation associated protein
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of KRTDAP mRNA
CTD
PMID:28713220
NCBI chr 1:86,038,296...86,041,594
Ensembl chr 1:86,038,437...86,041,455
G
Lipa
lipase A, lysosomal acid type
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of LIPA mRNA
CTD
PMID:17547211
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Loricrin
loricrin cornified envelope precursor protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA
CTD
PMID:32076005
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
G
Lrig1
leucine-rich repeats and immunoglobulin-like domains 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of LRIG1 mRNA
CTD
PMID:28713220
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
G
Lss
lanosterol synthase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of LSS mRNA
CTD
PMID:17547211
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of MAFF mRNA
CTD
PMID:17547211
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Man1a2
mannosidase, alpha, class 1A, member 2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of MAN1A2 mRNA
CTD
PMID:17547211
NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:187,951,617...188,096,332
G
Maoa
monoamine oxidase A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA
CTD
PMID:32076005
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA
CTD
PMID:32076005
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32076005 PMID:32920012 PMID:34571074
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK3 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32076005 PMID:32920012 PMID:34571074
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcm2
minichromosome maintenance complex component 2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of MCM2 mRNA
CTD
PMID:17547211
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Me1
malic enzyme 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ME1 mRNA
CTD
PMID:28713220
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mgat2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of MGAT2 mRNA
CTD
PMID:17547211
NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177
G
Mgst1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA
CTD
PMID:32076005
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mt1-ps3
metallothionein 1, pseudogene 3
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of MT1E mRNA
CTD
PMID:28713220
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
G
Mt2A
metallothionein 2A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of MT2A mRNA
CTD
PMID:28713220
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
multiple interactions decreases response to substance
ISO
[MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate MYCN protein results in decreased susceptibility to Antimony Potassium Tartrate
CTD
PMID:10348353
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Ndrg2
NDRG family member 2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of NDRG2 mRNA
CTD
PMID:17547211
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA
CTD
PMID:32076005
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of NFKBIA mRNA
CTD
PMID:17547211
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nkx3-1
NK3 homeobox 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA; Antimony Potassium Tartrate results in increased expression of NKX3-1 protein bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]
CTD
PMID:29462692
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]
CTD
PMID:34571074
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of NQO1 mRNA; Antimony Potassium Tartrate results in increased expression of NQO1 protein [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of NQO2 mRNA
CTD
PMID:28713220
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of NR0B2 mRNA
CTD
PMID:17547211
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Os9
OS9, endoplasmic reticulum lectin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of OS9 mRNA
CTD
PMID:17547211
NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
G
Osm
oncostatin M
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]
CTD
PMID:32076005
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pbx1
PBX homeobox 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA
CTD
PMID:32076005
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PCNA protein
CTD
PMID:34571074
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of PDIA4 mRNA
CTD
PMID:17547211
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pgc
progastricsin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of PGC mRNA
CTD
PMID:17547211
NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of PGD protein
CTD
PMID:28713220
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pgm1
phosphoglucomutase 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of PGM1 mRNA
CTD
PMID:28713220
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pgm3
phosphoglucomutase 3
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of PGM3 mRNA
CTD
PMID:28713220
NCBI chr 8:87,518,317...87,536,021
Ensembl chr 8:87,517,701...87,536,022
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:32076005
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA
CTD
PMID:32076005
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pir
pirin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA
CTD
PMID:32076005
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pitx1
paired-like homeodomain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA
CTD
PMID:32076005
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
G
Pml
PML nuclear body scaffold
affects localization multiple interactions increases degradation
ISO
Antimony Potassium Tartrate affects the localization of PML protein Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein] Antimony Potassium Tartrate results in increased degradation of PML protein mutant form
CTD
PMID:9834237
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Ppih
peptidylprolyl isomerase H
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of PPIH mRNA
CTD
PMID:17547211
NCBI chr 5:132,906,324...132,924,341
Ensembl chr 5:132,906,328...132,924,267
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA
CTD
PMID:32076005
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Psph
phosphoserine phosphatase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of PSPH mRNA
CTD
PMID:17547211
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of PTTG1 mRNA
CTD
PMID:17547211
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rara
retinoic acid receptor, alpha
increases degradation
ISO
Antimony Potassium Tartrate results in increased degradation of RARA protein mutant form
CTD
PMID:9834237
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rbpms
RNA binding protein, mRNA processing factor
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of RBPMS mRNA
CTD
PMID:17547211
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
G
Rfc2
replication factor C subunit 2
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of RFC2 mRNA
CTD
PMID:17547211
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rnaseh2a
ribonuclease H2, subunit A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of RNASEH2A mRNA
CTD
PMID:17547211
NCBI chr19:23,186,325...23,196,045
Ensembl chr19:23,186,383...23,196,041
G
Rnh1
ribonuclease/angiogenin inhibitor 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of RNH1 protein
CTD
PMID:28713220
NCBI chr 1:196,269,293...196,281,763
Ensembl chr 1:196,269,293...196,281,910
G
Rptn
repetin
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of RPTN mRNA
CTD
PMID:28713220
NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:179,060,017...179,065,910
G
Ryr1
ryanodine receptor 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of RYR1 mRNA
CTD
PMID:28713220
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
S100a2
S100 calcium binding protein A2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of S100A2 mRNA
CTD
PMID:28713220
NCBI chr 2:176,077,081...176,078,325
G
S100a8
S100 calcium binding protein A8
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of S100A8 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A8 protein
CTD
PMID:28713220
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of S100A9 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A9 protein
CTD
PMID:28713220
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SCD mRNA
CTD
PMID:17547211
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sephs2
selenophosphate synthetase 2
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SEPHS2 mRNA
CTD
PMID:17547211
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SERPINB1 mRNA
CTD
PMID:17547211
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Serpinc1
serpin family C member 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SERPINC1 mRNA
CTD
PMID:17547211
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA
CTD
PMID:32076005
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sik1
salt-inducible kinase 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of SIK1 mRNA
CTD
PMID:17547211
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA
CTD
PMID:32076005
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Snrpa
small nuclear ribonucleoprotein polypeptide A
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of SNRPA mRNA
CTD
PMID:17547211
NCBI chr 1:82,481,770...82,490,540
Ensembl chr 1:82,481,770...82,490,538
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA
CTD
PMID:32076005
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sprr1a
small proline-rich protein 1A
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SPRR1A mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1A protein
CTD
PMID:28713220
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sprr1b
small proline-rich protein 1B
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SPRR1B mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1B protein
CTD
PMID:28713220
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sprr3
small proline-rich protein 3
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SPRR3 mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR3 protein
CTD
PMID:28713220
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
G
Sqle
squalene epoxidase
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SQLE mRNA
CTD
PMID:17547211
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA
CTD
PMID:32076005
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srsf1
serine and arginine rich splicing factor 1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SRSF1 mRNA
CTD
PMID:17547211
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
G
Srsf5
serine and arginine rich splicing factor 5
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of SRSF5 mRNA
CTD
PMID:17547211
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of SRXN1 mRNA
CTD
PMID:28713220
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of ST6GALNAC4 mRNA
CTD
PMID:17547211
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA
CTD
PMID:32076005
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Sult1c3
sulfotransferase family 1C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA
CTD
PMID:32076005
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
G
Sult1e1
sulfotransferase family 1E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA
CTD
PMID:32076005
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2b1
sulfotransferase family 2B member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA
CTD
PMID:32076005
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Sumo1
small ubiquitin-like modifier 1
affects localization multiple interactions
ISO
Antimony Potassium Tartrate affects the localization of SUMO1 protein Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein]
CTD
PMID:9834237
NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:61,077,435...61,108,761
G
Tardbp
TAR DNA binding protein
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of TARDBP mRNA
CTD
PMID:17547211
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
G
Tgm1
transglutaminase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA
CTD
PMID:32076005
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of TNFAIP3 mRNA
CTD
PMID:17547211
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA
CTD
PMID:17547211
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tob1
transducer of ErbB-2.1
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of TOB1 mRNA
CTD
PMID:17547211
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Tp63
tumor protein p63
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA
CTD
PMID:32076005
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tpi1
triosephosphate isomerase 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of TPI1 mRNA
CTD
PMID:28713220
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tsc22d3
TSC22 domain family, member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:32076005
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tspan7
tetraspanin 7
decreases expression
ISO
Antimony Potassium Tartrate results in decreased expression of TSPAN7 mRNA
CTD
PMID:17547211
NCBI chr X:12,208,783...12,306,092
Ensembl chr X:12,208,783...12,306,131
G
Tuft1
tuftelin 1
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of TUFT1 mRNA
CTD
PMID:17547211
NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:182,260,398...182,306,192
G
Txn1
thioredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA
CTD
PMID:32076005
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
increases expression multiple interactions
ISO
Antimony Potassium Tartrate results in increased expression of TXNRD1 mRNA [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD
PMID:17547211 PMID:28713220 PMID:32076005
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyms
thymidylate synthetase
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of TYMS mRNA
CTD
PMID:17547211
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ube2c
ubiquitin-conjugating enzyme E2C
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of UBE2C mRNA
CTD
PMID:17547211
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions increases expression
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA Antimony Potassium Tartrate results in increased expression of UGT1A6 mRNA
CTD
PMID:28713220 PMID:32076005
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Zwint
ZW10 interacting kinetochore protein
increases expression
ISO
Antimony Potassium Tartrate results in increased expression of ZWINT mRNA
CTD
PMID:17547211
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all